hypertrophy has led to the proposal that hypertrophy itself issue.
other complex apparata, including the pulmonary, renal calcium pump, or Ca -ATPase of the sarcoplasmic and neural systems [1] . reticulum (SERCA2a) is now recognized as a major It is now becoming increasingly evident that the regulator of cardiac contractile function. This pump drives 21 myocardial cell, besides being a target for a number of the Ca uptake into the sarcoplasmic reticulum, therefore hormones and growth factors [2,3] also behaves as a accounting for the speed of cardiac relaxation. Consonant source for peptides that may play a crucial role in signal with a crucial role of SERCA2a in contractile regulation is transduction processes in the heart [4] [5] [6] [7] . Hence, the the observation that a decrease in SERCA2a gene expresmyocardium adapts to hormonal, genetic and mechanical sion and activity can be observed in a wide variety of stimuli by triggering a number of paracrine, autocrine and pathological conditions associated with cardiac hyperintracrine responses that represent the plight that is impacttrophy and / or failure [16, 17] . ing the homeostasis of the myocardial cells throughout
In this issue of Cardiovascular Research, Bluhm et al. specific pathologic processes [8] [9] [10] [11] . The complexity of [18] examined the possibility that transgenic gene expresthe overall picture is given by the finding that heart sion of SERCA2a in mice may compensate for the mechanical dysfunctions and failure are often the funcabnormalities in cardiac performance associated with tional end-point of processes involving an impairment of pharmacologically-induced hypothyroidism. The authors the architectural plan of the myocardial cell [1, 12] . In this assessed SERCA2a gene and protein expression in hearts regard, heart development is one of the first morphogenetic from euthyroid and hypothyroid mice of wild-type or events occurring in the embryo and is a complex phenomSERCA2a transgene status. The study revealed a decrease enon involving cell proliferation and differentiation, as in SERCA2a mRNA and protein expression in hypothyroid well as tissue organization. The observation that a rewild-type animals, as compared with euthyroid wild-type capitulation of the fetal program occurs during myocardial mice. Such a decrease was associated with a prolongation in the time course of both the contraction and relaxation in expressing SERCA2a were made hypothyroid, the expresFuture directions in the dissection of the interplay(s) sion of SERCA2a mRNA did not differ from that observed among the molecular determinants that define a normal in euthyroid wild-type mice. Noteworthy, the increase in myocardial architecture and contractility will involve the SERCA2a mRNA and protein detected in hypothyroid development of engineered mouse models overexpressing transgene mice in comparison to hypothyroid wild-type these cardiac morphogenetic elements. These animal animals was able to elicit a functional improvement in both models will represent a valuable tool for investigating the contraction and relaxation profile of papillary muscle.
whether genes targeted for mammalian cardiogenesis and Such a restoration of the contractile performance appears potentially involved in the restoration of a normal cardiac to be specifically linked to the overexpression of the morphogenesis may also act to rescue a normal contractile SERCA2a gene elicited in transgenic mice, since a previactivity. The establishment of these engineered animals ous characterization of the SERCA2a transgenic model will also help to understand whether ventricular chamber performed by the same group [19] revealed no changes in dysfunctions simply arise as a result of decreased number the expression of other calcium handling-related genes, and / or altered architecture of cardiac myocytes or whether including the genes encoding for the ryanodine receptor, a primary contractile defect is associated with an impaired
calsequestrin, phospholamban and the Na / Ca -exprogram of cardiogenesis. Addressing this issue may be of changer.
particular relevance in the course of metabolic disorders, Demonstration of the feasibility of a transgene-mediated including hypothyroidism and diabetes, that encompass functional approach in the rescue of a hypothyroid phenoboth a derangement of cardiac architecture and an impairtype may both disclose new perspectives and place new ment of myocardial contractility. challenges. In the study by Bluhm et al. [18] , mice were made hypothyroid at the age of 2 to 3 months, a period in the adult life span which is far away from the developmenReferences tal changes occurring in the embryo during the specification of the cardiac lineage. It is now documented that and differentiation [20, 21] . These hormones act on nuclear 766. receptors belonging to the Steroid-Thyroid-Retinoid shown to activate the retinoic X receptor-a (RXRa) and to tive heart failure that initially manifests itself as a decrease tion and in specifying the architectural plan of the cardiac [12] Li E, Sucov HM, Lee K-F, Evans RM, Jaenisch R. Normal
